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Background: BrdU is a commonly used reagent in cell proliferation assays, and WST-1 measurement is widely used
to detect cell viability. However, no previous study has formally reported the combination of the two assays, which
may be used to detect the proliferation and viability simultaneously. In this study, we examined the effect of adding
BrdU 2 h prior to the WST-1 assay and tried to test the possibility of the combined detection using rat airway
smooth muscle cells.
Results: The WST-1 measurements obtained from the combined detection were consistent with those obtained
from the separate detection, which suggested that the addition of BrdU 2 h prior to the WST-1 analysis did not
affect the WST-1 results. The BrdU measurements obtained from the combined detection also demonstrated the
same trend as that obtained from the separate detection, and dosages of 200, 400 and 800 ng/ml testing reagent
significantly inhibited the proliferation of rat airway smooth muscle cells.
Conclusions: Our study suggests that the BrdU and WST-1 measurements can be applied simultaneously without
mutual interference, which may increase the efficacy and consistency of these measurements to a certain extent.
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Proliferation is an important characteristic of living cells,
and increases in cell numbers are the result of cell div-
ision. Many methods have been established for cell num-
ber quantification, and all of these have underlying
assumptions, relative merits, and must be applied appro-
priately. Both direct and indirect techniques have been
used for measuring cell proliferation. The counting of
cell numbers using a hemocytometer and the clonogenic
assay are the classical methods used for direct measure-
ment [1]. The indirect measurement methods included
isotope-related methods and non-radioactive assays. Iso-
topes, such as 3H, 76Br, 15 N and 13C, are used to detect
cell proliferation, but radioactive products and/or special
facilities are required. Non-radioactive assays are widely
used because of lower toxicity, convenient operation and
low cost. Alamar blue has been adopted to determine* Correspondence: yyq@shutcm.edu.cn
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unless otherwise stated.the proliferation of different cell types [2]. A highly sen-
sitive, fluorescence-based microplate assay has also been
applied for cell number determination [3]. The in situ
hybridization of histone mRNA and immunohistochem-
istry with Ki-67 are preferable techniques for assessing
cell proliferation in paraffin-embedded renewing tissues
[4]. The expression levels of BrdU (Bromodeoxyuridine),
Ki-67, and PCNA (proliferating cell nuclear antigen)
have been compared by immunohistochemical labeling
to evaluate the proliferation of epidermal basal cells, and
the results showed that there was no substantial differ-
ence among the three methods [5].
As a commonly used reagent in cell proliferation assay,
BrdU is a thymidine analog that can incorporate into the
newly replicated DNA of S-phase cells. BrdU has a high
labeling efficiency and can be detected within a short
time. It is reported that the labeling efficiency of BrdU
was 94% in bone marrow stromal cells [6] and approxi-
mately 10% of the BrdU-labeled mesenchymal stem cells
could still be detected after 25 d [7]. By using BrdU, the
newly synthesized DNA in primary murine hippocampals is an Open Access article distributed under the terms of the Creative
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ation time of gastrulating chick embryos was found to
range from 2 h to 10 h [9]. Moreover, various methods
can be used to apply the BrdU reagent. The proliferation
of hippocampal progenitor cells has been quantified by
labeling with 50 mg/kg BrdU through intraperitoneal in-
jection [10]. The injection of 200 mg BrdU through the
intravenous route has been used to evaluate the bio-
logical role of the HER (human epidermal growth factor
receptor) gene family of receptor tyrosine kinases [11].
The BrdU labeling method is compatible with other
methods. It is reported that the RNA quality of the
stained section could be preserved after BrdU immu-
nostaining in bovine mammary tissue [12]. However,
the combination of BrdU labeling with WST-1 (2-(4-
iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium, mono-sodium salt), which is frequentlyFigure 1 The comparison between the simultaneous and direct assay
BrdU showed that there was no significant difference among the different
performed after WST-1 assay showed that there was a significant difference
200, 400 and 800 ng/ml significantly inhibited the proliferation of ASM cell
24 h after the addition of the MRP-14 protein at concentrations of 1, 10, 50
no significant difference among the different dosages of the MRP-14 prote
the addition of the MRP-14 protein at concentrations of 1, 10, 50, 100, 200,
of 200, 400 and 800 ng/ml significantly inhibited the proliferation of ASM c
the result obtained with 1 ng/ml (P < 0.05). All of the data were expressedused to detect cell viability, has not been formally inves-
tigated. The examination of the cell proliferation and
viability of the same cell population will double the data
and reduce the amount of work, which may also result
in saving expensive testing reagents and labor. In this
study, we examined the effect of adding BrdU 2 h prior
to the WST-1 assay and tried to test the possibility of
the combined detection.
Results
After adding the BrdU into the 96-well plate for 2 h, the
WST-1 measurement was performed. The WST-1 result
(combined) showed that there was no significant differ-
ence among the different dosages of the MRP-14 protein
(F = 1.617, P > 0.05, Figure 1a), although certain dosages
showed the tendency of inhibition on the ASM cells.
After the WST-1 measurement, the BrdU assay was thens. a) The WST-1 measurement obtained 2 h after the addition of
dosages of the MRP-14 protein (P > 0.05). b) The BrdU measurement
among the different groups (P < 0.05). The protein dosages of 100,
s at 24 h (P < 0.05). c) The WST-1 measurement was conducted directly
, 100, 200, 400 and 800 ng/ml. The result manifested that there was
in (P > 0.05). d) The direct BrdU measurement was obtained 24 h after
400 and 800 ng/ml. The result showed that the protein concentrations
ells at 24 h (P < 0.05). *indicates a significant difference compared with
as mean ± SD, n = 4.
Figure 2 Schematic of the simultaneous BrdU and WST-1
measurements. The MRP-14 protein was added at concentrations
of 1, 10, 50, 100, 200, 400 and 800 ng/ml. Before adding the WST-1
reagent into the plate at the time point of 24 h, the BrdU was
added and incubated for 2 h. After the WST-1 measurement was
conducted, the BrdU assay was performed.
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cant difference among the different groups (F = 60.586,
P < 0.05). The dosages of 100, 200, 400 and 800 ng/ml
protein inhibited the proliferation of the ASM cells at
24 h and were significantly different from that of the
1 ng/ml (P < 0.05, Figure 1b). The results also demon-
strated that low concentrations of the MRP-14 proteins
(1, 10 ng/ml) had the tendency to stimulate cell growth.
At the same time, the standard WST-1 measurement
was conducted directly after the addition of the same
concentrations of the MRP-14 protein. The WST-1
result (standard) demonstrated that there was no signifi-
cant difference among the different dosages of the MRP-
14 protein (F = 2.443, P > 0.05, Figure 1c). The fact sug-
gested that the addition of BrdU 2 h prior to the WST-1
examination did not disturb the WST-1 result and thus
provided a possibility for the combined detection. In
order to confirm that the proliferation status of the
ASM cells was not disturbed by the WST-1 reagent, the
BrdU measurement was performed directly 24 h after
the addition of the same concentrations of the MRP-14
protein. The result showed that there was a significant
difference among the different groups (F = 10.559, P <
0.05). The results obtained with dosages of 200, 400 and
800 ng/ml were significantly different from that obtained
with 1 ng/ml (P < 0.05, Figure 1d), which suggested that
these dosages of the MRP-14 protein inhibited the pro-
liferation of ASM cells at 24 h. The 1 and 10 ng/ml
MRP-14 protein stimulated the proliferation of ASM
cells, which were consistent to the previous experiment.
Discussion
BrdU was first introduced to examine cell proliferation
in the central nervous system in 1988 and is useful for
labeling nascent DNA in living cells and tissues [13,14].
WST-1 is a cell-impermeable, sulfonated tetrazolium salt
that can be used to examine cell viability without killing
the cells [15]. It will be cost-efficient to combine the
BrdU and WST-1 measurements for the simultaneous
detection of cell proliferation and viability.
The low concentration and short application time of
BrdU are the first components that allows its possible
combination with the WST-1 assay. Early study showed
that BrdU could induce many biological responses of
genotoxicity, such as locus mutation and the fragile sites
expression in the human genome [16]. It is reported that
long-term BrdU treatment for 6 d significantly increased
the level of the alpha V-associated integrin and inhibited
cell growth in both culture medium and soft agar [17].
However, short-term exposure to BrdU is relative safe
and may have less harmful biological reactions. For
example, there was no evidence of the anti-mitogenic
action of BrdU after 18 h incubation with CD4+ T cells
[18], which suggested that short-term treatment withBrdU did not disturb the cell cycle. The study showed
that BrdU (10, 60 and 120 mg/ml for 4 d) had no cyto-
toxic effects on hippocampal cells and immature neu-
rons proliferation [19]. Moreover, low concentration of
BrdU had no inhibitory effect on adult neural progeni-
tor cells [20] and did not prevent the differentiation of
preadipocyte [21]. In the present study, the level of
BrdU used was 10 μM and the incubation time was
only 2 h before the WST-1 measurement, which may
account for the lack of disturbance found on cell
viability.
The chemical nature of WST-1 is the second compo-
nent allowing the possible simultaneous measurements
of these two reagents. WST-1 is a light-red, highly sen-
sitive tetrazolium that produces water highly soluble
formazan after the NADPH oxidase reduction in mito-
chondria. Because WST-1 is different from the cell-
permeable MTT, which produces insoluble formazan
that accumulates inside cells, the toxicity of WST-1 to
cells is significantly decreased. It is very likely that the
non-toxic WST-1 is compatible with BrdU and the same
cells can be used to conduct the subsequent experi-
ments. Our study showed that the result of the BrdU
assay performed after the WST-1 measurement was
consistent with the result obtained from the direct BrdU
examination, which confirmed that WST-1 did not
affect cell proliferation.
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Chemicals and reagents
All of the chemicals used were of analytical grade. The
BrdU cell proliferation ELISA kit was purchased from
Roche Applied Science, the WST-1 cell viability kit was
purchased from Beyotime Biotechnology Inc. The other
important components were the following: DMEM
(DMEM Dulbecco's Modified Eagle Medium, Hyclone),
FBS (fetal bovine serum, Gibco), 1 × PBS (phosphate
buffered saline, Hyclone), 0.25% trypsin (Sigma), 10,000
U/ml penicillin and 10,000 μg/ml streptomycin (Hyclone),
100 cm2 cell culture dishes (Corning), 96-well plate
(Corning), spectrophotometer (Bio-tek). The purified
MRP-14 (migration inhibitory factor-related protein
14) recombinant protein was used as the testing re-
agent in the study [22].
Cell preparation and culture
The isolation and culture of the airway smooth muscle
cells (ASM cells) were performed according to the
previous description [23]. Briefly, after redundant tissue
dissection and washing of the rat trachea in sterile, ice-
cold, HPPS solution (10.0 mM HEPES, 130.0 mM NaCl,
5.0 mM KCl, 1.2 mM MgCl2 · 6H2O, 10.0 mM glucose,
pH = 7.4), enzyme digestions (2.0 mg/ml collagenase IV
and 0.05% elastase) was conducted for 30 min at 37°C.
The pellet was then resuspended and cultured in
DMEM with 10% FBS. The ASM cells were confirmed
by the immunofluorescence of SM α-actin. The cul-
ture medium was renewed every 2–3 days and experi-
ments were performed with cells at passages 3–10.
The study design
The MRP-14 protein was given at doses of 1, 10, 50,
100, 200, 400, 800 ng/ml (final concentration, the same
as below) into the 96-well plate and incubated for 24 h.
BrdU (10 μl/well, 10 μM) was added into the plate 2 h
before the WST-1 measurement in order to maintain
BrdU in the well for 4 h. 10 μl WST-1 was added at the
time point of 24 h, then incubated for 2 h and measured.
After the WST-1 measurement, the BrdU examination
was performed according to the manufacturer’s instruc-
tions. The schematic of the simultaneous BrdU and
WST-1 measurements was showed in Figure 2.
BrdU measurement
The BrdU measurement was conducted according to the
standard protocol of manufacturer. After culturing the
ASM cells (5000/well) in the 96-well plate overnight, the
MRP-14 protein was given to obtain final concentrations
of 1, 10, 50, 100, 200, 400, 800 ng/ml and incubated for
24 h. BrdU (10 μl/well, 10 μM) was added and incubated
for 4 h at 37°C. The medium was moved by tapping.
The cells were then fixed and incubated for 30 min atroom temperature. After thorough removal of the fix so-
lution by tapping, 100 μl/well working solution of BrdU
antibody conjugated with peroxidase was added and in-
cubated for 90 min at room temperature. The wells were
rinsed three times with the washing solution (200 μl/
well), and the substrate solution (100 μl/well) was added.
The absorbance was monitored at 370 nm.
WST-1 measurement
The WST-1 measurement was performed according to
the standard protocol of manufacturer. Briefly, the ASM
cells (5000/well) were cultured into the 96-well plate
and incubated overnight. Then the MRP-14 protein was
added to obtain final concentrations of 1, 10, 50, 100,
200, 400, 800 ng/ml and incubated for 24 h. 10 μl
WST-1 was added and incubated for another 2 h at
37°C in the incubator. The absorbance was monitored
at 450 nm.
Statistics
The Statistical significances among the different groups of
the BrdU and WST-1 measurements were calculated using
one-way ANOVA followed by LSD posthoc test. P value
less than 0.05 was considered significant.
Conclusion
The study demonstrated that BrdU and WST-1 mea-
surements can be applied simultaneously without mu-
tual interference, which may be useful for the cellular
functions examination and efficacy improvement.
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